Ellex Medical Lasers Announces Further Positive Data For 2RT Treatment Of Early AMD

ADELAIDE, Australia, May 21, 2014 (GLOBE NEWSWIRE) -- Ellex Medical Lasers Limited (AUST:ELX), a pioneer in medical technologies for the diagnosis and treatment of eye disease, today announced data from a 24-month follow up of the pilot study investigating the efficacy of the Company's proprietary Retinal Rejuvenation Therapy (2RT™) in the treatment of early AMD. The data was presented in summary form by Dr. Erica L. Fletcher of the University of Melbourne, at the Association for Research in Vision and Ophthalmology (ARVO) 2014 Annual Meeting in Orlando, FL and is currently being considered for publication in a peer-reviewed journal.

Help employers find you! Check out all the jobs and post your resume.